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Senescence regulates macrophage
activation and angiogenic fate at sites
of tissue injury in mice
Jennifer Kelly, Aslam Ali Khan, Jiyi Yin, Thomas A. Ferguson, and Rajendra S. Apte
Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri, USA.

Abnormal angiogenesis plays a key role in diseases of aging such as heart disease, certain cancers, and
eye diseases including age-related macular degeneration. Macrophages have been shown previously to be
both anti- and proangiogenic, and their role in regulating angiogenesis at sites of tissue injury is critical
and complex. In this study, we analyzed cytokine gene expression patterns of mouse macrophages by realtime quantitative PCR and tested the functional effects of senescence on gene expression and macrophage
polarization. Following laser injury to the retina, IL-10 was upregulated and Fas ligand (FasL), IL-12, and
TNF-α were downregulated in ocular macrophages of old mice (>18 months of age). Downregulation of
FasL on macrophages led to a loss of the antiangiogenic phenotype, as evidenced by the inability of these
macrophages to inhibit vascular endothelial cells. Our results demonstrate that senescence, FasL, and IL-10
are key determinants of macrophage function that alter the growth of abnormal postdevelopmental blood
vessels in disease processes including blinding eye disease.
Introduction
Immune vascular interactions can play an important role in regulating angiogenesis during development as well as in diseases of
aging such as cancers, atheromatous heart disease, and blinding
eye disease (1–4). There are several lines of evidence that suggest
that macrophages play a critical role in this process. Macrophages
have been established as necessary and sufficient in inducing
regression of lens vasculature during embryonic development (5).
They play a key role in inhibiting the growth of abnormal blood
vessels in the eye in age-related macular degeneration (AMD), the
leading cause of blindness in people over 50 years of age (1, 6).
Blindness in AMD occurs largely from the exudative (wet) form of
the disease, which is characterized by the development of abnormal blood vessels underneath the retina, i.e., choroidal neovascularization (CNV) (7, 8).
On the other hand, alternative lines of evidence have also implicated macrophages in promoting abnormal blood vessel growth in
murine tissue injury models (9). In the tumor micromilieu, there
is evidence that macrophage influence on angiogenesis is complex (10). These cells can be pro- or antiangiogenic depending on
their polarization, which in turn is regulated by several cytokines
in the tissue microenvironment (11–13). Recent studies have also
demonstrated that IL-10–/– mice are significantly impaired in their
ability to generate CNV after laser-induced tissue injury to the
eye (1). IL-10 promotes angiogenesis in the eye and inhibits antiangiogenic macrophage function at the site of tissue injury. This
contrasts with the proangiogenic macrophage function that has
been described in other CNV studies (9). Polarization of macrophages can play a pivotal role in determining the ultimate effector
function of these cells (13). Macrophages stimulated in presence
Nonstandard abbreviations used: AMD, age-related macular degeneration; CNV,
choroidal neovascularization; Ct, threshold cycle; FasL, Fas ligand; HMVEC, human
dermal microvascular endothelial cell.
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of IFN-γ, LPS, or GM-CSF produce high levels of cytokines such as
IL-12, IL-23, IL-6, and TNF-α with low levels of IL-10. This signature highlights an antiangiogenic macrophage that is also important in antibacterial and inflammatory functions. Our laboratory
has previously demonstrated that GM-CSF–cultured macrophages
can inhibit CNV upon injection in to the eyes of host mice at the
time of tissue injury (1). In the presence of IL-10, IL-4, or IL-13,
macrophages become polarized to a proangiogenic phenotype
characterized by high levels of IL-10 and low levels of proinflammatory cytokines such as IL-6 and TNF-α.
It is important to understand the factors that regulate macrophage activity and determine their control of postdevelopmental
angiogenesis, especially because abnormal angiogenesis in the
aged eye in AMD leads to severe vision loss and blindness. In this
study, we evaluated the effect of senescence on macrophage function and angiogenesis and its implications for aging-associated
diseases such as AMD in a laser-induced model of angiogenesis.
Laser-induced injury is a surrogate tissue injury model for CNV
and has been an excellent predictor of therapies that have subsequently been approved for the treatment of this condition. We also
explored the critical role of IL-10 in these processes.
Results
Aging is associated with enhanced angiogenesis. We have previously
demonstrated that IL-10–/– mice have significantly reduced ocular
angiogenesis following laser injury (1). IL-10 is a critical regulator
of macrophage migration and influx into the site of tissue injury
and of the subsequent development of CNV (1). Regulation of ocular angiogenesis is particularly important in the elderly who develop CNV in the eye as a function of unbridled angiogenesis that
eventually leads to blindness. In order to directly test the effect of
tissue injury on angiogenesis in aged animals, we lasered the eyes
of old mice (>18 months of age) and compared the CNV response
on day 7 after laser injury with that of young mice (<3 months of
age). Old mice had significantly more CNV than did young mice
(Figure 1), a finding similar to previous reports that tested mice
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Figure 1
Quantification of CNV in young (<3 months of age) and old (>18 months of age) mice on day 7 following laser injury. Mice were perfused intracardially with FITC-dextran (green) prior to harvesting eyeballs and sclerochoroidal flat mounts were made in order to quantify CNV volumes by
confocal microscopy. (A) Old mice demonstrated significantly more CNV than did young mice. Error bars represent SEM. *P < 0.05 vs. old. (B
and C) Representative CNV from a young (B) and an old (C) mouse.

over 16 months of age (14). These findings suggest that antiangiogenic responses in old mice are impaired.
Macrophages from senescent mice fail to inhibit postdevelopmental
angiogenesis. Because macrophages have been shown to inhibit
angiogenesis after laser-induced injury to the eye, we isolated
F4/80+ splenic macrophages from C57BL/6 young or old mice by
positive selection. In order to determine whether there is a functional difference between these macrophages in their ability to
regulate angiogenesis, 1 × 105 macrophages from young and old
mice were injected in to the eyes of old C57BL/6 host mice on
the day of laser, and CNV response was measured on day 7 following laser injury. Macrophages from young mice significantly
inhibited the CNV response, but macrophages from old mice
failed to demonstrate any inhibition compared with the sham
control mice injected with PBS (Figure 2). We have previously
demonstrated that bone marrow–derived macrophages infiltrate
into the laser lesions in the choroid after tissue injury (1). Here we
isolated and dissected laser lesions as described in Methods, and
F4/80 immunostaining demonstrated no significant differences
in macrophage numbers within the laser lesions of young and
old mice (data not shown). Enriched macrophage cytokine gene
expression signature within these lesions was assessed by quantitative real-time PCR. Uninjured choroidal tissue was used as a
control. We analyzed the cytokine profile of ocular macrophages
isolated from young and old mice by measuring their cytokine
gene expression 6 hours after tissue injury by real-time quantitative PCR. Macrophage-rich CNV lesions from old mice demonstrated significant downregulation of IL-12, TNF-α, and Fas
ligand (FasL) 6 hours after the laser-induced injury, while these
genes were highly upregulated or relatively unaltered in young

mice (Figure 3, A–C). In addition, IL-6 and IL-23 were upregulated
after tissue injury in young mice at levels exponentially higher
than those seen in old mice (Figure 3, D and E). IL-10 expression
was upregulated in both young and old mice (Figure 3F).
IL-10 regulates macrophage function and promotes angiogenesis. These
results are especially interesting given our previously published
observations that IL-10–/– mice, which lack native IL-10, have
reduced angiogenesis after laser injury to the eye (1). IL-10 is a
key regulator of macrophage polarization and regulation of
angiogenesis (1, 13). We tested the ability of IL-10–/– macrophages
to inhibit CNV after intraocular injection to determine whether
macrophage polarization affects angiogenic fate, i.e., CNV. Host
C57BL/6 mice were injected intraocularly with 1 × 105 F4/80+
splenic macrophages from either syngeneic IL-10–/– mice or WT
mice on the day of laser. Control mice were injected with PBS.
Macrophages from IL-10–/– mice inhibited CNV even more efficiently than did those from young syngeneic WT mice, suggesting
that the presence of native IL-10 causes a drift of macrophage
function to a proangiogenic phenotype, in contrast to the effect of
senescence on macrophage function (Figure 4). Given that IL-10
is such a critical cytokine in regulating abnormal angiogenesis
in the eye, we wanted to test the gene expression of IL-10 in the

Figure 2
Assessment of CNV inhibition following intraocular injection of macrophages (1 × 105 cells/eye). Old mice were injected with PBS (sham) or
macrophages from either old or young mice on the day of laser, and
CNV was measured at day 7 following laser injury. Macrophages isolated from young mice demonstrated significant inhibition of CNV following intraocular injection in to old eyes, while macrophages isolated
from old mice fail to inhibit CNV. *P < 0.02, young vs. old.
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Figure 3
Quantitative real-time PCR gene expression analysis of macrophage-rich lesions
from young and old mouse eyes after
laser injury. Matching unlasered tissue
was used as the baseline control. Macrophages from old mice demonstrated
significant (asterisks) downregulation
of IL-12 (A, P = 0.0068627), TNF-α (B,
P = 0.0370), and FasL (C, P = 0.0302)
compared with young mice. IL-6 (D,
P = 0.00017) and IL-23 (E, P = 0.1024)
were upregulated at levels exponentially
higher in young mice than in old mice.
(F) IL-10 was upregulated in both young
and old mice, although baseline levels
of IL-10 (P = 0.0701) were significantly
higher in old mice than young mice. RQ,
relative quantification.

posterior compartment of the eye at baseline in young mice and
compare the levels to those of old mice using IL-10–/– eyes as a
negative control. As shown in Figure 5, dissected sclerochoroidal tissue from old C57BL/6 mice at baseline had exponentially
higher levels of IL-10 than did young WT or IL-10–/– mice. This
result suggests that the micromilieu in old mice is rich in IL-10
and might create an environment that promotes polarization of
infiltrating macrophages to a proangiogenic M2 phenotype. In
addition, high baseline levels of IL-10 in old mice might explain
the modest upregulation of IL-10 in macrophage-rich lesions of
old mice compared with young mice after injury (Figure 3F). We
then compared the effect of tissue injury on cytokine gene expression of macrophages within the laser lesions from eyes of IL-10–/–
mice with that in C57BL/6 syngeneic WT young mice.
Macrophage-enriched CNV lesions from IL-10–/– mice
demonstrated marked upregulation of IL-6, TNF-α,
IL-12, and FasL after laser injury in contrast to WT mice
(Figure 6, A–D). As expected, IL-10–/– mice had a paucity
of IL-10 gene expression, but WT mice had significant
upregulation of IL-10 after injury (Figure 6E). IL-23 was
upregulated in both young and IL-10–/– mice (data not
shown). This signature defines the IL-10–/– macrophage
as a TNFhi, IL-6hi, IL-12hi, IL-23hi, FasLhi, antiangiogenic
macrophage and is consistent with our results that (a)
IL-10–/– mice had reduced CNV and (b) IL-10–/– mouse–

derived macrophages inhibited CNV after injection into the eye
of a WT mouse. Our results also demonstrated that as mice age,
senescent macrophages had elevated IL-10 at baseline and after
injury. Old macrophages have a TNFlo, IL-6lo, IL-12lo, IL-23lo,
FasLlo, and IL-10 hi phenotype after tissue injury to the eye, a phenotype that impairs their ability to regulate angiogenesis.
Effect of IL-10 and IFN-γ on macrophage polarization and angiogenesis.
The presence of IL-10, as seen in the tissue micromilieu in old mice,
was associated with a proangiogenic phenotype, as seen in Figure 1
and in previous studies (1). In order to directly assess the effect of
polarizing cytokines such as IL-10 or IFN-γ on macrophages and
their regulation of angiogenesis, we isolated F4/80+ macrophages
from the spleens of WT mice and incubated them with 100 ng/ml

Figure 4
Assessment of CNV inhibition following intraocular injection
of macrophages (1 × 105 cells/eye). Syngeneic old mice were
injected with PBS (sham) or macrophages from young WT or
IL-10–/– mice on the day of laser, and CNV was measured at
day 7 following laser injury. (A) Macrophages isolated from
IL-10–/– mice demonstrated significant inhibition of CNV following intraocular injection into old eyes, at levels beyond
those seen following intraocular injection of macrophages
from young WT mice. *P < 0.008 vs. sham. (B–D) Representative CNV from mice injected with IL-10–/– macrophages (B),
young WT macrophages (C), and sham-injected mice (D).
The Journal of Clinical Investigation
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Figure 5
Relative gene expression of IL-10 at baseline in dissected sclerochoroidal tissue from IL-10–/– mice, young WT mice, and old WT mice.
IL-10 gene expression was performed using real-time PCR; data are
represented using the IL-10–/– eye as the baseline. *P < 0.001 vs. old.

of IL-10 or IFN-γ for 24 hours prior to injection. Host WT mice
were lasered on day 0, and their eyes were injected with 1 × 105
F4/80+ splenic macrophages. IL-10–treated macrophages failed
to inhibit CNV, while IFN-γ–treated macrophages demonstrated
significant inhibition of CNV (Figure 7). These data clearly highlight the important role of IL-10 as a proangiogenic cytokine and
demonstrate that in presence of IL-10, macrophages polarize to an
M2 phenotype and fail to demonstrate antiangiogenic properties.
Aging impairs the ability of macrophages to regulate vascular endothelial
cell proliferation. The results thus far suggest that as mice age, their
macrophages lose antiangiogenic function and that IL-10 is a key
proangiogenic regulator of macrophage fate and function. We have
previously demonstrated that macrophages can directly inhibit vascular endothelial cell proliferation and angiogenesis in vivo (1). We
wanted to test directly whether senescence-associated alterations in
macrophage gene expression impair the ability of macrophages to
inhibit the growth and proliferation of vascular endothelial cells.
Thioglycollate-induced peritoneal macrophages (effectors) were
harvested from WT young, IL-10–/–, gld, or old mice and incubated
with human dermal microvascular endothelial cells (HMVECs; targets) at a 25:1 ratio in order to assess the effect of macrophages on
proliferation of HMVECs. As shown in Figure 8, while macrophages

from young and IL-10–/– mice significantly inhibited the proliferation of HMVECs, macrophages from old and gld mice failed to do
so. The effect was contact dependent: macrophages from gld or old
mice placed in transwells above the target HMVECs did not inhibit
or stimulate proliferation when compared with macrophages from
young or IL-10–/– mice placed in transwells (data not shown). This
confirms that the loss of antiangiogenic function of senescent macrophages is likely caused by downregulation of FasL and suggests
that old macrophages might actually promote abnormal angiogenesis as seen in diseases of aging such as AMD, atheromatous heart
disease, and certain cancers.
Discussion
CNV in AMD is responsible for more blindness in people over
50 years of age than any other ocular disease (7, 8). Our present
findings demonstrated that components of innate immunity
influenced angiogenesis and that subsets of macrophages exhibited diverse effects on aberrant angiogenesis. Senescence has been
shown to influence macrophage function, activation, and polarization (15). In the laser-induced tissue injury model, old mice
developed significantly higher volumes of CNV compared with
young mice emulating the human disease. Older eyes also had
significantly elevated levels of IL-10 at baseline compared with
eyes from young mice. Higher levels of IL-10 create a potentially
proangiogenic environment in the senescent mouse eye (1). We
hypothesized that variations in IL-10 levels in the local micromilieu lead to altered polarization of aged macrophages and macrophages from IL-10–/– mice. Quantitative PCR analysis of ocular

Figure 6
Quantitative real-time PCR gene
expression analysis of macrophage-rich lesions from young WT
and IL-10–/– mouse eyes after laser
injury. Matching unlasered tissue
was used as the baseline control.
(A–D) Macrophages from IL-10 –/–
mice demonstrated upregulation
of IL-6 (A, P = 0.0558), TNF-α (B,
P = 0.3579), IL-12 (C, P = 0.1824),
and FasL (D, P = 0.4569) compared
with young mice. (E) IL-10 was
upregulated in young mice and deficient in IL-10–/– mice. *P = 0.0513.
3424
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Figure 7
Ability of macrophages to inhibit CNV after treatment with polarizing cytokines. F4/80+ macrophages were isolated from the spleens of
C57BL/6 young WT mice, treated with 100 ng/ml IL-10 or IFN-γ, and then
injected in the eyes of host WT mice on the day of laser (1 × 105 cells/eye).
Macrophages treated with IFN-γ significantly inhibited CNV, while macrophages treated with IL-10 failed to do so. *P < 0.000003 vs. sham.

antiangiogenic (11–13). Polarization of macrophages determines
their ability to regulate angiogenesis. It might be possible in the
future to design immunotherapies that could potentially exploit
the ability to convert macrophages to an antiangiogenic phenotype by disrupting IL-10 function in order to limit complications
of AMD such as visual impairment and blindness.
Methods
macrophage-rich injured tissue from old mice showed significant
upregulation of IL-10 after tissue injury, with associated downregulation of FasL, IL-12, TNF-α, and IFN-γ, a phenotype similar to the
more traditionally defined M2 macrophages and one that leads to
an impaired ability of senescent macrophages to regulate abnormal angiogenesis. We have previously demonstrated that FasL on
macrophages is critical to the cells’ antiangiogenic function (1).
In the present study, we demonstrated that reduced expression of
FasL on senescent macrophages was associated with an M2 phenotype of these cells and correlated with impaired antiangiogenic
function of these cells. In addition, F4/80+ macrophages from old
mice failed to inhibit CNV upon injection in to the eye and failed
to inhibit the proliferation of vascular endothelial cells, consistent
with the proangiogenic phenotype of these macrophages.
The results presented here are important to our understanding
of macrophages as regulators of angiogenesis. We demonstrated
that IL-10 was a key regulator of this process and that a lack of
IL-10 in their microenvironment made macrophages antiangiogenic. On the contrary, as macrophages aged, senescence-induced
changes in these cells increased baseline levels of IL-10 expression.
Old macrophages also demonstrate reduced expression of surface
FasL as well as antiangiogenic cytokines such as IL-12 and TNF-α.
This cytokine profile of old macrophages rendered these mice
more susceptible to injury-associated angiogenesis. Macrophages
from old mice also demonstrated a blunted ability to upregulate
IL-6 compared with cells from young mice or IL-10–/– mice. TNF-α,
IFN-γ, FasL, IL-12, and IL-6 are associated with the antiangiogenic
macrophage (1, 13). A lack of antiangiogenic surveillance function
of macrophages may explain why people over 50 years of age are
highly susceptible to diseases with dysregulated angiogenesis such
as AMD and certain cancers. These results also explain previous
studies that have demonstrated that macrophages can be pro- or

Laser-induced model of CNV. Rupture of Bruch’s membrane with laser was
used to initiate CNV in 5- to 7-week-old mice as described previously (1).
Briefly, mice were anesthetized using intraperitoneal ketamine hydrochloride (86.9 mg/kg) and xylazine (13.4 mg/kg), and their pupils were dilated
with 1% tropicamide. Using krypton red laser, 4 laser burns were placed
around the optic nerve (0.05 seconds, 50 μm, 150 mW). Seven days after
laser, the mice were anesthetized as described above and perfused intraventricularly with fluorescein-labeled dextran. The mice were euthanized with
CO2 inhalation, and their eyes were harvested for tissue processing. A dissecting microscope was used to remove the cornea and lens and to gently
separate the retina from the underlying choroid and sclera. Microscissors
were used to make 4 radial incisions in the sclerochoroidal “eyecup” in
order to prepare choroidal flat mounts on glass slides. The tissues were
incubated in 4% paraformaldehyde for 45 minutes and washed 3 times
with 3% bovine serum albumin. A drop of fixative (Prolong) and a glass
coverslip were placed on each slide. The choroidal flat mounts were analyzed for presence of CNV by confocal microscopy. The extent of choroidal
neovascularization was quantified by Metamorph Imaging software.
Animal research. Mice were purchased from The Jackson Laboratory
(C57BL/6 WT, IL-10–/–) or from the National Institute for Aging, NIH
(C57BL/6 old mice, >18 months of age). All animal experiments were
approved by the Animal Studies Committee at Washington University in
St. Louis School of Medicine. All experiments contained at least 3 mice per
group and were repeated a minimum of 2 times.
Positive selection of macrophages and intraocular injection. Positive selection
of F4/80+ macrophages was performed as described previously (1). Briefly,

Figure 8
Effect of senescence on macrophage ability to regulate proliferation
of vascular endothelial cells. HMVECs were cultured alone, unlabeled
[H(UNL)] or labeled [H(L)], or were cultured with macrophages from
young WT [M/H(25:1)B6], old WT [M/H(25:1)Old], gld [M/H(25:1)Gld],
and IL-10–/– [M/H(25:1)IL-10–/–] mice for 12 hours prior to measuring
the proliferation of HMVEC with [3H] thymidine (TdR). Young WT and
IL-10–/– macrophages inhibited the proliferation of HMVECs, while old
and gld macrophages failed to do so. *P = 0.009; **P < 0.00086.
The Journal of Clinical Investigation
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F4/80+ macrophages were purified from dissociated mouse spleen cells by
positive selection using magnetic separation (Stemcell Technologies Inc.).
Cell purity was greater than 90% by flow cytometry. Cells were injected into
the vitreous cavities of mouse eyes using a 33-gauge Hamilton needle on
the same day as laser treatment. We used 1 × 105 macrophages for intravitreal injections based on previously published dose-response experiments
(1). Control mice were injected with PBS.
Isolation of ocular macrophages. Sclerochoroidal eyecups were made from
eyes with or without prior laser injury as described above. We have previously demonstrated that macrophages migrate into the laser-induced
tissue injury lesions in the choroid (1). In eyes subjected to laser injury,
careful attention was paid to dissecting out the laser lesions containing
the infiltrating macrophages for gene expression analysis. The presence
of macrophages within the laser lesions at 6 hours was confirmed by
immunostaining with F4/80-APC antibody (data not shown). Unlasered
matching sclerochoroidal tissue from syngeneic mice was obtained as a
control for comparison and quantification.
Real-time PCR and gene expression analysis. Total RNA was prepared from
harvested ocular tissue 6 hours after laser injury using the RNeasy mini kit
(Qiagen). Unlasered ocular tissue was harvested as control. RNA was purified by a gDNA eliminator spin column in order to minimize the amount
of gDNA cross-contamination. cDNA was prepared using the High Capacity cDNA Archive Kit (Applied Biosystems). Relative levels of target gene
expression were measured on the 7500 Real-time RT-PCR system (Applied
Biosystems). For fluorescence measurement and assay preparation, FAM490–based Taqman Gene Expression Assay Mix (Applied Biosystems) specific for each gene of interest and Taqman Universal Master Mix (Applied
Biosystems) were used. Relative Quantification PCR analysis was performed using the ABI 7500 SDS Software. The threshold cycle (Ct) values
were measured for our endogenous control (β-actin or 18s rRNA) and the
genes of interest at the logarithmic phase of amplification. The ΔCt values
for the calibrator (negative baseline control) were calculated as the difference between the Ct value of the endogenous control and the target gene of
interest. This ΔCt value for the calibrator was then compared with the ΔCt
value of each of our unknown cDNA samples, and the difference of these 2
values was taken to achieve the ΔΔCt value for each gene. The relative fold
expression difference was calculated as 2–ΔΔCt and graphed.
Taqman gene expression assay mixes. Primer and probe sets were as follows:
ActB, Mm00607939_s1; 18s rRNA, Hs99999901_s1; FasL, Mm00438864_
1. Apte, R.S., Richter, J., Herndon, J., and Ferguson,
T.A. 2006. Macrophages inhibit neovascularization
in a murine model of Age-related macular degeneration. PLoS Med 3:e310–e320.
2. Nakao, S., et al. 2005. Infiltration of COX-2expressing macrophages is a prerequisite for IL-1βinduced neovascularization and tumor growth.
J. Clin. Invest. 115:2979–2991. doi:10.1172/JCI23298.
3. Taylor, P.R., et al. 2005. Macrophage receptors
and immune recognition. Annu. Rev. Immunol.
23:901–944.
4. Hansson, G.K. 2005. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med.
352:1685–1695.
5. Lobov, I.B., et al. 2005. WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Nature. 437:417–421.
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m1; TNF-α, Mm00443258_m1; IL-6, Mm00446190_m1; IL-10,
Mm00439616_m1; IL-23, Mm00518984_m1; IL-12, Mm01288989_m1.
Data are represented as gene expression increase or decrease in macrophage-rich eye lesions from old, young, or IL-10–/– mice after injury compared with uninjured tissue within the same group.
Vascular endothelial cell proliferation assay. Young WT C57BL/6 (6–8 weeks
of age), syngeneic IL-10–/–, syngeneic gld (FasL-deficient), and syngeneic old
mice were injected intraperitoneally with 3% thioglycollate for 5 days. Macrophages were harvested with sterile PBS from the peritonea of these mice
and cultured in RPMI-1640 plus 10% FCS overnight. Macrophages were
then washed with RPMI-1640 to remove nonadherent cells and stimulated
with LPS (100 ng/ml) for 12 hours. Subsequently, HMVECs (5 × 104 cells;
Lonza) in log phase were put in EGM2V (Lonza) in 96-well round-bottomed plate for adherence. After stimulation, macrophages were washed
to remove LPS and cocultured with HMVECs for another 12 hours. Macrophages were then flushed by repeated and gentle pipetting; HMVECs were
incubated with 40 μCi/ml [3H] thymidine (TRA61; GE Health Care) for 12
hours. Plate was harvested and read using a Topcount harvester and micro
plate reader (Packard).
Statistics. One-tailed Student’s t test was used for statistical analysis. P less
than 0.05 was considered statistically significant.
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